Status: Recruiting
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial
Participants needed: 165
Trial details
Age: 45+Biological sex: AllType: InterventionalSponsor: Avisi Technologies Inc.Updated: Dec 15, 2025Locations: 12
Eligibility criteria
Open angle, pseudoexfoliative or pigmentary glaucoma [+4]
Angle closure glaucoma [+6]